SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 90 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $213,000 | -12.7% | 6,808 | -29.5% | 0.11% | +58.0% |
| Q4 2016 | $244,000 | -69.3% | 9,652 | -69.9% | 0.07% | -58.2% |
| Q3 2016 | $794,000 | +21.4% | 32,103 | 0.0% | 0.16% | +1.2% |
| Q2 2016 | $654,000 | +33.5% | 32,103 | 0.0% | 0.16% | +7.2% |
| Q1 2016 | $490,000 | +48.9% | 32,103 | +36.8% | 0.15% | +74.7% |
| Q3 2015 | $329,000 | -17.3% | 23,462 | 0.0% | 0.09% | +16.0% |
| Q2 2015 | $398,000 | +40.1% | 23,462 | 0.0% | 0.08% | +50.0% |
| Q1 2015 | $284,000 | +45.6% | 23,462 | 0.0% | 0.05% | +61.3% |
| Q4 2014 | $195,000 | -4.4% | 23,462 | 0.0% | 0.03% | +19.2% |
| Q3 2014 | $204,000 | -14.3% | 23,462 | +7.8% | 0.03% | +4.0% |
| Q2 2014 | $238,000 | +22.1% | 21,772 | 0.0% | 0.02% | +8.7% |
| Q1 2014 | $195,000 | – | 21,772 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |